Emergency Agitation in T&A

Not Applicable

Completed

• Conditions: Healthy
• Interventions: Drug: remifentanil; Drug: normal saline

• Registration Number: NCT01152476
• Lead Sponsor: Seoul National University Bundang Hospital

Brief Summary

Sevoflurane has been used commonly in pediatric anesthesia since 1990. However, it has caused more emergency agitation (EA) that other inhalation agents and the incidence is up to 80%. Therefore, lower minimum alveolar concentration of sevoflurane will reduce the EA when it is used with remifentanil in pediatric general anesthesia.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-04
• Study First Submitted: 2010-06-25
• Study First Submitted QC: 2010-06-28
• Study First Posted: 2010-06-29
• Primary Completion: 2010-10
• Study Completion: 2010-10
• Status Verified: 2011-01
• Last Update Submitted: 2011-01-05
• Last Update Posted: 2011-01-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 42

Inclusion Criteria

• American Society of Anesthesiologist physical status I or II
• 2-6 year-old children
• patients undergoing tonsillectomy and adenoidectomy

Exclusion Criteria

• upper respiratory disease
• mental retardation

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
group SR	remifentanil	-
group S	normal saline	-

Primary Outcome Measures

Name	Time	Method
emergency agitation	during 1 hour after recovering of anesthesia	at post-anesthetic care unit

Trial Locations

Locations (1)

Seoul National University Bundang Hospital; 🇰🇷 Seongnam-si, Gyeonggi-do, Korea, Republic of